Bucillamine is an antirheumatic agent developed from tiopronin. It is mainly used in Japan and Korea. Activity is mediated by the two thiol groups that the molecule contains. Research done in USA showed positive transplant preservation properties. Bucillamine is used for the treatment of acute gout flare in subjects with moderate to severe gout.
API's & Drug Standards
|Appearance||off white solid form|
Send us your enquiry for Bucillamine. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.
We value your input so if you have suggestions regarding new applications for Bucillamine email us and we will include your contribution on the website.